PFHO · Pacific Health Care Organization Inc

Track PFHO — free

$0.94 +0.01 (+1.08%) At close · Oct 14

Rebalance outlook locked

Market Cap

$12.03M

12.80M

Volume · Oct 14 41.4K Avg daily vol (3M) 10.74K

Up next

Latest filing: 10-Q

filed Aug 4, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

View all 122 metrics

Revenue (TTM)

$6.44M

Trailing 12 months

Net income (TTM)

$978,754

Trailing 12 months

Revenue growth YoY

+2.8%

Year over year

Operating margin

14.4%

Trailing 12 months

P / E (TTM)

10.4

Trailing earnings · reciprocal yield 9.6%

FCF yield

4.8%

TTM · current market cap

Return on invested capital

—

Trailing 12 months

Net cash

—

Latest balance sheet

Dividend yield

—

Trailing 12 months

Shares change YoY

+0.0%

Year over year

Price change (1Y)

-30.4%

Trailing year

Short interest

0.0%

Latest settlement · 1.0 days to cover

View all 122 metrics

Quarterly results

Revenue Net income Net loss

▲6.8% $1.50M $174,863 '24 Q3 ▲2.4% $1.63M $295,762 '24 Q4* ▲30.1% $1.82M $292,663 '25 Q1 ▲12% $1.73M $636,907 '25 Q2 ▲5.7% $1.59M $223,002 '25 Q3 ▼2.6% $1.58M $235,075 '25 Q4* ▼17.7% $1.50M $193,669 '26 Q1 LATEST ▲2.8% $1.77M $327,008 '26 Q2

* Q4 derived as the full year minus Q1 to Q3.

Equibles Rating

blended score · not investment advice

Overall

Neutral

SellHoldBuy

Technical Neutral Momentum Very Weak Sentiment Neutral Fundamentals Excellent Quant / Vol Very High

Market backdrop VIX 19 · elevated Equity put/call 0.69

Technical

price trend

Neutral

50 / 200-day cross No cross

Price vs 200-day avg −12%

below

Price vs 50-day avg +4%

above

RSI (14) 48

neutral

MACD trend Negative

52-week position 24%

mid-range

Volume (OBV) Confirms

volume backs price

Momentum

relative strength

Very Weak

1-month return −6%

trailing

6-month return −12%

trailing

YTD return −28%

this year

Relative strength −21%

vs S&P · 6-mo

Sentiment

smart money

Neutral

Trend (MA cross) No cross

50d $1 › 200d $1 — 200d above 50d

Institutional flow Flat

No 13F holder data

Insider flow Flat

No net insider activity over 90 days

Short interest Falling

0.00% of float · ▼ -96.7% MoM · 1.0 days cover

Volume signal Normal

Volume near normal

Institution breadth Steady

No 13F holder history

Squeeze score 17

low risk · 0–100

Fundamentals

Excellent

Revenue growth +11%

Y/Y

EPS growth +57%

Y/Y

Free cash flow $1.1M

Valuation P/E 10.4

below peers

Quant / Vol

risk profile

Very High

Volatility 84%

annualized · 1-yr

Max drawdown −42%

past year

ATR 3.5%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Neutral

2 · 4 · 1

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

−12% Bearish

Price vs 50-day avg

+4% Bullish

RSI (14)

48 Neutral

MACD trend

Negative Bearish

52-week position

24% Neutral

Volume (OBV)

Confirms Neutral

Market signals — smart money & positioning

Bullish · 1 of 6

Trend (MA cross) No cross

50d $1 › 200d $1 — 200d above 50d

Institutional flow Flat

No 13F holder data

Insider flow Flat

No net insider activity over 90 days

Short interest Falling

0.00% of float · ▼ -96.7% MoM · 1.0 days cover

Volume signal Normal

Volume near normal

Institution breadth Steady

No 13F holder history

Price context

position in its 52-week range

Range low $1 Now $1 · 24% Range high $1

vs 200-day avg -12% vs 50-day avg +4%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings

Metric	Latest	Period	YoY
Customer A percentage of total operating revenue	28%	the three months ended June 30, 2026 filing	—
Customer B percentage of total operating revenue	13%	the three months ended June 30, 2026 filing	—
Customer C percentage of total operating revenue	12%	the three months ended June 30, 2026 filing	—
Major customers' share of total sales	53%	the three months ended June 30, 2026 filing	—

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Healthcare Plans — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
PFHO Pacific Health Care Organization Inc this stock	$12.03M	-27.7%	+10.7%	10.4	0.0%
UNH Unitedhealth Group Inc	$381.11B	+28.7%	+11.8%	—	1.8%
CVS CVS HEALTH Corp	$120.84B	+19.1%	+7.8%	24.9	1.3%
ELV Elevance Health, Inc.	$96.21B	+27.0%	+12.5%	18.9	2.2%
CI Cigna Group	$83.47B	+14.8%	+11.2%	13.1	2.6%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Short & Settlement

Short Interest Falling

Shares short

110

Days to cover: 1.0d
Change: -3.2K sh

View

Short Volume

Short vol %

50%

As of: Oct 22, 2026

Short Total

View

Fails to Deliver

FTD shares

430

Value: $550
As of: Apr 27, 2026

View

Off-Exchange

Off-exchange %

100.0%

Week of: Sep 14, 2026

Off-exch Lit

View

Financials

Revenue (FY)

$6.7M

Net income (FY): $1.4M
EPS diluted: $0.11

View

Filings

SEC Filings

Latest

10-Q

Filed: Aug 4, 2026
This year: 3

View

Performance

	5D	20D	120D	MTD	YTD
PFHO	+0.0%	-6.0%	-12.2%	-6.0%	-27.7%
SPY	-1.0%	+2.1%	+8.6%	+0.9%	+12.9%
vs SPY	+1.0%	-8.1%	-20.8%	-6.9%	-40.6%

Key facts CIK 1138476 CUSIP 69439P407 Visit website Investor relations

PFHO · Pacific Health Care Organization Inc

Price & Indicators

Up next

Metrics snapshot

Quarterly results

Equibles Rating

Technicals

Key metrics

Versus peers

At a glance

Performance